Plenary Session Will Unveil Impact of Non-Tobacco Factors in Lung Cancer Risk

Lung Cancer Beyond Smoking: Outdoor Air Pollution and Lung Cancer

Surgical Challenges and Opportunities in Locally Advanced NSCLC

Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology

FURTHER Study Moves the Needle Farther on Targeted Therapy Directed at Atypical EGFR Mutations in NSCLC

Aumolertinib After CRT Significantly Improves PFS in EGFR-mutated Unresectable NSCLC

Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy

IASLC Looks Back at 50 Years of Growth, Collaboration, and Progress in Lung Cancer

Study Shows Patients at Lowest Risk May Benefit from Longer Intervals Between Lung Cancer Screening

Analyzing the CheckMate Trials: How do Clinicians Choose the Winning Strategy for Patients With Resectable NSCLC?

Phase II FLOWERS Trial Unveils Potential New First-Line Therapy Option